HY004 cell injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HY004 cell injection, covering 2025-08-08 to 2025-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]